September 4, 2020 the Board of the Novus Therapeutics, Inc. appointed Jon Kuwahara to serve as the company’s interim principal executive officer following Mr. Gregory Flesher’s resignation. Mr. Kuwahara is the company’s Senior Vice President Finance & Administration of the company and serves as the company’s principal financial and accounting officers.